Coordinate Modulation of Glycolytic Enzymes and OXPHOS by Imatinib in BCR-ABL Driven Chronic Myelogenous Leukemia Cells. Here, ABL1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.